Essential Strategies for Compliance with USP <800>
The risks of occupational exposure to hazardous drugs has been known since the 1970s. Since 1980, guidance documents from the American Society of Health-System Pharmacists (ASHP) and the National Institute for Occupational Safety and Health (NIOSH) have provided advice to healthcare providers who manage these agents, but many organizations have not taken the necessary steps to ensure safety. On February 1, 2016 United States Pharmacopeia (USP) General Chapter <800>: "Hazardous Drugs: Handling in Healthcare Settings" was published, and will provide the first enforceable standards concerning hazardous drugs beginning on July 1, 2018.
Is your organization ready? The safety issues identified in USP <800> are not new, but they unfortunately have not been adopted by many organizations leaving practitioners at risk for unnecessary exposure to hazardous drugs. While USP <797> and other compounding chapters focus on patient safety, USP <800> is designed to address the protection of personnel and environment. Unlike other standards, USP <800> involves the management of facility design, personal protective equipment, proper decontamination and cleaning, and other related topics.
Learn the requirements now. Join us as our speaker describes practical strategies to ensure compliance with USP <800> including methods to promote both patient and worker safety, as well as answer your most pressing questions on this new regulation.
Interdisciplinary teams are encouraged to attend together:
- Hospital and Health System Executives and Managers
- Quality and Risk Management Leaders
- Physician, Pharmacy, and Nursing Leaders
- Patient and Medication Safety Officers
- Frontline Practitioners, including Prescribers, Nurses, and Pharmacists
- Interdisciplinary Teams are Encouraged to Attend Together
Following completion of the webinar, participants will be able to:
- Identify the resource document that defines hazardous drugs
- List the three categories of hazardous drugs
- Cite three sources that provide safety information concerning hazardous drugs
- Describe elements of an Assessment of Risk
- Compare an ideal facility to your current site to determine safety gaps to be addressed
Patricia C. Kienle, RPh, MPA, FASHP
Director, Accreditation and Medication Safety
Cardinal Health Innovation Delivery Solutions
Matthew P. Fricker Jr. MS, RPh, FASHP
Institute for Safe Medication Practices
This webinar is approved for 1.5 hours of Pharmacy Continuing Education and 1.0 hours of Nursing Continuing Education. There is no additional charge for the continuing education credits for this webinar.
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 1.5 hours (0.15 CEUs). Educational Review Systems is also approved for pharmacy continuing education by the state of Florida.
Live Continuing Education Credits must be completed by 4/16/2016. We are unable to process the request after this date.
Enduring Continuing Education Credits will expire on 3/16/2018 but must be completed within 30 days of the date you watched the program. We are unable to process the request after this date.